AGAPE ATP CORPORATION Selling, General and Administrative Expense
AGAPE ATP CORPORATION (ATPC) reported Selling, General and Administrative Expense of $159.52 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2020-05-14
- AGAPE ATP CORPORATION selling, general and administrative expense for the quarter ending 2020-03-31 was $159.52K, a 465.14% increase year-over-year.
- AGAPE ATP CORPORATION selling, general and administrative expense for the quarter ending 2019-12-31 was $167.99K, a 586.25% increase year-over-year.
- AGAPE ATP CORPORATION selling, general and administrative expense for the quarter ending 2019-09-30 was $144.28K, a 21.64% increase year-over-year.
- AGAPE ATP CORPORATION selling, general and administrative expense for the quarter ending 2019-06-30 was $101.58K, a 219.48% increase year-over-year.
- AGAPE ATP CORPORATION selling, general and administrative expense for fiscal 2019 was $240.52K, a 14.00% decline from fiscal 2018.
- AGAPE ATP CORPORATION selling, general and administrative expense for fiscal 2018 was $279.68K, a 271.12% increase from fiscal 2017.
- AGAPE ATP CORPORATION selling, general and administrative expense for fiscal 2017 was $75.36K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-03-31 | $159.52K 10-Q · filed 2020-05-14 | $327.50K derived: sum of 2 quarters · filed 2020-05-14 | $471.79K derived: sum of 3 quarters · filed 2020-05-14 | $573.37K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-12-31 | $167.99K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | $312.27K 10-K · filed 2020-03-27 | $413.86K derived: sum of 3 quarters · filed 2020-03-27 | $442.08K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-09-30 | $144.28K 10-Q · filed 2019-11-12 | $245.87K derived: sum of 2 quarters · filed 2020-03-27 | $274.09K derived: sum of 3 quarters · filed 2020-05-14 | $298.57K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-06-30 | $101.58K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $129.81K derived: sum of 2 quarters · filed 2020-05-14 | $154.29K derived: sum of 3 quarters · filed 2020-05-14 | $240.52K 10-K · filed 2020-03-27 | $607.36K 10-K · filed 2019-09-13 | |
| 2019-03-31 | $28.23K 10-Q · filed 2020-05-14 | $52.70K derived: sum of 2 quarters · filed 2020-05-14 | $138.94K 10-Q · filed 2019-05-13 | $203.12K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $24.48K 10-Q · filed 2019-02-15 | $63.07K 10-K · filed 2020-03-27 | $174.89K derived: sum of 3 quarters · filed 2020-03-27 | $203.76K derived: sum of 4 quarters · filed 2020-03-27 | ||
| 2018-09-30 | $118.62K 10-Q · filed 2019-11-12 | $38.59K 10-Q · filed 2018-11-13 | $150.41K derived: sum of 2 quarters · filed 2020-03-27 | $179.28K derived: sum of 3 quarters · filed 2020-03-27 | $303.70K derived: sum of 4 quarters · filed 2020-03-27 | |
| 2018-06-30 | $31.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $60.66K derived: sum of 2 quarters · filed 2020-03-27 | $185.08K derived: sum of 3 quarters · filed 2020-03-27 | $279.68K 10-K · filed 2020-03-27 | $265.68K 10-K · filed 2018-09-27 | |
| 2018-03-31 | $28.86K 10-Q · filed 2019-05-13 | $153.28K derived: sum of 2 quarters · filed 2019-05-13 | $247.88K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $124.42K 10-Q · filed 2019-02-15 | $217.77K 10-Q · filed 2019-02-15 | ||||
| 2017-09-30 | $93.35K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $75.36K 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |